Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Trademark Destroying Cancer at the Speed of Light

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jun 28, 2021 9:13pm

279 Views

Post# 33464302

RE:RE:Trademark Destroying Cancer at the Speed of Light

I also took Enriquesuave's investigative reporting as a positive. I still expect the quarterly report sometime in the second half of July but we should get something at or before the AGM.

Yajne wrote: Interesting that these trademark applications files immediately prior to the AGM. Expect we'll see these embedded in the AGM corporate deck in some fashion. Hopefully they'll soon share some additional&promising patient data as well.

enriquesuave wrote: https://uspto.report/TM/90789850